Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_assertion type Assertion NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_head.
- NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_assertion description "[Moreover, weak expression of ADAM23 in methylated cancer cells increased after treatment with 5-aza-2'-deoxycytidine (5-Aza-2'-dC), confirming that methylation was responsible for the gene downregulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_provenance.
- NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_assertion evidence source_evidence_literature NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_provenance.
- NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_assertion SIO_000772 21429053 NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_provenance.
- NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_assertion wasDerivedFrom befree-20150227 NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_provenance.
- NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_assertion wasGeneratedBy ECO_0000203 NP854598.RA5ixTT5ZXStvqy4cs_WS2IbmzYbOwRJLP7xtxgUt8RTg130_provenance.